Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) open the trading on Wednesday, with a bit cautious approach as it glided -3.57% to $11.87, before settling in for the price of $12.31 at the close. Taking a more long-term approach, AMLX posted a 52-week range of $2.60-$16.96.
The Healthcare sector firm’s twelve-monthly sales growth has been -78.71% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -78.71%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 65.17%. This publicly-traded company’s shares outstanding now amounts to $109.77 million, simultaneously with a float of $91.69 million. The organization now has a market capitalization sitting at $1.30 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.85, while the 200-day Moving Average is $8.67.
Amylyx Pharmaceuticals Inc (AMLX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Amylyx Pharmaceuticals Inc’s current insider ownership accounts for 16.51%, in contrast to 94.74% institutional ownership. According to the most recent insider trade that took place on Dec 01 ’25, this organization’s Chief Medical Officer sold 6,580 shares at the rate of 14.35, making the entire transaction reach 94,418 in total value, affecting insider ownership by 175,756.
Amylyx Pharmaceuticals Inc (AMLX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
Amylyx Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 65.17% and is forecasted to reach -1.15 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 33.77% through the next 5 years, which can be compared against the -78.71% growth it accomplished over the previous five years trading on the market.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Trading Performance Indicators
Let’s observe the current performance indicators for Amylyx Pharmaceuticals Inc (AMLX). It’s Quick Ratio in the last reported quarter now stands at 13.70. In the same vein, AMLX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.80, a figure that is expected to reach -0.34 in the next quarter, and analysts are predicting that it will be -1.15 at the market close of one year from today.
Technical Analysis of Amylyx Pharmaceuticals Inc (AMLX)
[Amylyx Pharmaceuticals Inc, AMLX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 5.39% While, its Average True Range was 23.39.
Raw Stochastic average of Amylyx Pharmaceuticals Inc (AMLX) in the period of the previous 100 days is set at 46.31%, which indicates a major rise in contrast to 5.07% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.81 that was higher than 0.75 volatility it exhibited in the past 100-days period.
